Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-27 @ 11:44 PM
Study NCT ID:
NCT01838694
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2013-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Sponsor:
Invion, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-17
First Submit QC Date:
None
Study First Post Date:
2013-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-01
Results First Submit QC Date:
None
Results First Post Date:
2017-01-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-05
Last Update Post Date:
2017-01-30
Last Update Post Date Type:
ESTIMATED